Expression of the NH2-terminal fragment of RasGAP in pancreatic β-cells increases their resistance to stresses and protects mice from diabetes

Diabetes

Volumn 58, Issue 11, 2009, Pages 2596-2606

  Yang, Jiang Yan ^a   Walicki, Jöel ^a   Jaccard, Evrim ^a   Dubuis, Gilles ^a   Bulat, Natasa ^a   Hornung, Jean Pierre ^a   Thorens, Bernard ^a   Widmann, Christian ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FATTY ACID; GROWTH ASSOCIATED PROTEIN; PROTEIN KINASE B;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE RAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BRAIN; CELL DIVISION; DIABETES MELLITUS, EXPERIMENTAL; DNA, COMPLEMENTARY; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROMOTER REGIONS, GENETIC; RAS GTPASE-ACTIVATING PROTEINS; RATS;

EID: 70350550102     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0104     Document Type: Article

References (48)

1. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, Woo M. Caspase-3-dependent β-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 2005;25:3620-3629 (Pubitemid 40559568)
2. Maedler K, Donath MY. Beta-cells in type 2 diabetes: a loss of function and mass. Horm Res 2004;62(Suppl. 3):67-73
3. Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004;47:581-589
4. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9:231-241
5. Yan N, Shi Y. Mechanisms of apoptosis through structural biology. Annu Rev Cell Dev Biol 2005;21:35-56
6. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M. Mechanisms of β-cell death in type 2 diabetes. Diabetes 2005;54(Suppl. 2):S108-S113 (Pubitemid 43343338)
7. Moritz W, Meier F, Stroka DM, Giuliani M, Kugelmeier P, Nett PC, Lehmann R, Candinas D, Gassmann M, Weber M. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1α expression. FASEB J 2002;16:745-747
8. Ilieva A, Yuan S, Wang RN, Agapitos D, Hill DJ, Rosenberg L. Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol 1999;161:357-364 (Pubitemid 29278791)
9. Efanova IB, Zaitsev SV, Zhivotovsky B, Kohler M, Efendic S, Orrenius S, Berggren PO. Glucose and tolbutamide induce apoptosis in pancreatic β-cells: a process dependent on intracellular Ca2+ concentration. J Biol Chem 1998;273:33501-33507 (Pubitemid 129754428)
10. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 1997;138:2610-2614 (Pubitemid 27215269)
11. Mandrup-Poulsen T. Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol 2003;66:1433-1440 (Pubitemid 38373330)
12. Eldor R, Yeffet A Baum K, Doviner V, Amar D, Ben Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, Melloul D. Conditional and specific NFκB blockade protects pancreatic β cells from diabetogenic agents. Proc Natl Acad Sci U S A 2006;103:5072-5077
13. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999;13:2905-2927
14. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-1274
15. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 2001;7:1133-1137
16. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001;108:1631-1638
17. Alliouachene S, Tuttle RL, Boumard S, Lapointe T, Berissi S, Germain S, Jaubert F, Tosh D, Birnbaum MJ, Pende M. Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J Clin Invest 2008;118:3629-3638
18. Yang J-Y, Widmann C. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol Cell Biol 2001;21:5346-5358 (Pubitemid 32702440)
19. Yang J-Y, Widmann C. The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NFκB activation. J Biol Chem 2002;277:14641-14646 (Pubitemid 34952532)
20. Yang J-Y, Walicki J, Michod D, Dubuis G, Widmann C. Impaired Akt activity down-modulation, caspase-3 activation, and apoptosis in cells expressing a caspase-resistant mutant of RasGAP at position 157. Mol Biol Cell 2005;16:3511-3520 (Pubitemid 41077065)
21. Yang J-Y, Walicki J, Abderrahmani A, Cornu M, Waeber G, Thorens B, Widmann C. Expression of an uncleavable N-terminal RasGAP fragment in insulin-secreting cells increases their resistance toward apoptotic stimuli without affecting their glucose-induced insulin secretion. J Biol Chem 2005;280:32835-32842 (Pubitemid 41368331)
22. Bulat N, Widmann C. Generation of a tightly regulated all-cis beta cell-specific tetracycline-inducible vector. BioTechniques 2008;45:411-420
23. Yang J-Y, Michod D, Walicki J, Murphy BM, Kasibhatla S, Martin S, Widmann C. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol Cell Biol 2004;24:10425-10436 (Pubitemid 39507879)
24. Mauricio D, Mandrup-Poulsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 1998;47:1537-1543 (Pubitemid 28445339)
25. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 1995;136:4790-4795 (Pubitemid 3002171)
26. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 2000;26:139-142 (Pubitemid 30158100)
27. Gorogawa S, Fujitani Y, Kaneto H, Hazama Y, Watada H, Miyamoto Y, Takeda K, Akira S, Magnuson MA, Yamasaki Y, Kajimoto Y, Hori M. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. Biochem Biophys Res Commun 2004;319:1159-1170
28. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004;428:332-337 (Pubitemid 38418805)
29. Norlin S, Ahlgren U, Edlund H. Nuclear factor-κB activity in β-cells is required for glucose-stimulated insulin secretion. Diabetes 2005;54:125-132
30. Lukic ML, Stosic-Grujicic S, Shahin A. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev Immunol 1998;6:119-128 (Pubitemid 28409872)
31. Zheng SJ, Lamhamedi-Cherradi SE, Wang P, Xu L, Chen YH. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 2005;54:1423-1428
32. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008;51:216-226
33. Mathis D, Vence L, Benoist C. β-Cell death during progression to diabetes. Nature 2001;414:792-798
34. Rhodes CJ. Type 2 diabetes: a matter of beta-cell life and death? Science 2005;307:380-384
35. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001;44:914-922
36. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851-860 (Pubitemid 35050963)
37. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY. Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 2001;50:1683-1690 (Pubitemid 33641583)
38. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-110 (Pubitemid 36042113)
39. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004;89:2601-2607
40. Haber EP, Procopio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R. New insights into fatty acid modulation of pancreatic β-cell function. Int Rev Cytol 2006;248:1-41 (Pubitemid 43238169)
41. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. β-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002;51:66-72
42. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415
43. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91 (Pubitemid 23036092)
44. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NFκB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85 (Pubitemid 29418447)
45. Kim S, Millet I, Kim HS, Kim JY, Han MS, Lee MK, Kim KW, Sherwin RS, Karin M, Lee MS. NFκB prevents β cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A 2007;104:1913-1918
46. Dohi T, Salz W, Costa M, Ariyan C, Basadonna GP, Altieri DC. Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice. EMBO Rep 2006;7:438-443
47. +/- mice. J Clin Invest 2003;111:1147-1160
48. Leiter EH. The NOD mouse: a model for insulidependent diabetes mellitis. In Current Protocols in Immunology. Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, Eds. John Wiley & Sons, 1997, p. 15.9.1-15.9.23